Table 1 Clinical features and laboratory findings at initial diagnosis in children and adolescents with GD

Group A (mild group, lower dose)

50/28

10.0 ± 2.2

9.6(7.7–11.9)

26(20.0-33.3)

15.84(9.39–22.39)

Group B (moderate group, higher dose)

27/10

9.4 ± 2.3

25.2(22.5–30.0)

56.5(52.4–60.7)

30.31(23.38–34.64)

Group C (severe group, higher dose)

15/9

8.4 ± 3.5

>30.8 ^a

96.1(84.1-137.5)

36.27 (26.47-40.0) ^c

Group D (severe group, much higher dose)

15/7

9.4 ± 3.2

>30.8 ^a

118.3(83.5-154.2)

37.25 (25.31-40.0) ^c

P^d

0.78

0.08

<0.01

<0.01

<0.01